Help

Search Results

2 results

  1. TSRC, Tob. Sci. Res. Conf., 2022, 75, abstr. 41

    Intention to purchase multiple e-cigarette flavors and its effect on projected use rate across tobacco user and nonuser groups

    FROST-PINEDA K.(1); POLSTER M.(2); CHAE R.(2); DIANNO N.(2); FREELAND R.(1)
    (1) RAI Services Company, Winston-Salem, NC, USA; (2) Naxion, Philadelphia, PA, USA
    Background: In order for a Premarket Tobacco Application to be authorized, tobacco product manufacturers must provide FDA with scientific evidence to support that a new tobacco product is appropriate for the protection of public health (APPH). FDA...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2021, Online, ST 45

    Meta-analysis study to establish population level estimates of NNAL in smokers and non-smokers

    AYALA-FIERRO F.(1); VERRON T.(2); LIZHNYAK P.(3); FREELAND R.(4); FROST-PINEDA K.(4); ELAMIN A.(5); PRASAD G.L.(4); SARKAR M.(3)
    (1) Juul Labs, Inc, U.S.A.; (2) Imperial Brands, U.K.; (3) Altria Client Services, U.S.A.; (4) RAI Services Company, U.S.A.; (5) Philips Morris International, Switzerland
    The purpose of this research (a project of the CORESTA Biomarkers Sub-Group) was to establish a population level estimate for the biomarker of cigarette smoke exposure, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), to serve as a baseline...